Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Qualisys Secures Commercial Agreement for OnTraq with Major European Football Club

QSYSPress release18.09.2026 klo 14.00

Qualisys has signed a commercial agreement for OnTraq, its end-to-end markerless motion capture system for elite athlete assessment, with a major football club in the Premier League.

OnTraq is Qualisys' proprietary, end-to-end markerless analysis system for athlete baseline testing and ongoing performance monitoring. It solves a long-standing industry trade-off - research-grade accuracy that used to require extensive setup, or fast tools that sacrificed data quality. OnTraq delivers both: teams can assess a full roster of approximately 20 athletes in 30 minutes, giving athletes objective insights and coaches reliable data for training design, load management, and return-to-play decisions.

"This agreement puts OnTraq in one of the most demanding environments in sport, and it's exactly where we want to prove its value as we grow into elite sports as a market,” says Ingemar Pettersson, CEO.

The club will run OnTraq as part of its regular testing routine, tracking player readiness and recovery without adding time or complexity to existing training and matchday schedules.

“Signing with a major club in the Premier League is exactly the validation we built OnTraq for - giving performance staff reliable, repeatable data without adding time or complexity to their day,” says Magnus Berlander, CTO.

Launched in January 2026, OnTraq is a strategic investment in markerless technology and a new customer group -elite sports organizations. The platform is delivered through a licensed subscription model, building recurring revenue for Qualisys as adoption grows across more teams.

For more information please contact:

Ingemar Pettersson, CEO
E-mail: Ingemar.pettersson@qualisys.com

Magnus Berlander, CTO
E-post: Magnus.Berlander@qualisys.com

About Qualisys Holding AB (publ)
Qualisys is a leading provider of motion capture technology and has a long history of supplying research, engineering, entertainment, and sports facilities with high-end camera systems and expertise in capturing and analyzing movements. Qualisys offers a wide range of products and services with its headquarter in Gothenburg, Sweden, and operations in Chicago, Singapore, Shanghai and Delhi. Qualisys is certified according to ISO 9001:2015 and ISO 27001:2023. The clinical products are compliant with Medical Device Directive 93/42/EEC and have FDA clearance (K171547).

Qualisys is listed on Nasdaq First North Premier Growth Market. The company’s Certified Adviser is Svensk Kapitalmarknadsgranskning AB.

Attachments
Qualisys Secures Commercial Agreement for OnTraq with Major European Football Club